Divalproex Sodium
- Product NDC
- 0615-7949
- 11-digit product format
- 006157949
- Labeler code
- 0615
- Product ID
- 0615-7949_6da9a46a-85cf-47a4-9c11-6ee1f3774d98
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Divalproex Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA079163
- Marketing category
- ANDA
- Marketing start
- 2011-10-01
- Marketing end
- 2021-10-31
- Substance
- DIVALPROEX SODIUM
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-7949-30 | 00615794930 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-7949-30) > 5 TABLET, DELAYED RELEASE in 1 BLISTER PACK | 6 blister pack | 2016-04-19 | 2021-10-31 | No | No | Current |
| 0615-7949-39 | 00615794939 | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-7949-39) | | 2016-04-15 | 2021-10-31 | No | No | Current |